SevenBridge Financial Group LLC Raises Holdings in The Procter & Gamble Company (NYSE:PG)

SevenBridge Financial Group LLC lifted its position in shares of The Procter & Gamble Company (NYSE:PGFree Report) by 5.4% in the 3rd quarter, according to its most recent 13F filing with the SEC. The firm owned 30,989 shares of the company’s stock after acquiring an additional 1,579 shares during the quarter. Procter & Gamble makes up 0.9% of SevenBridge Financial Group LLC’s investment portfolio, making the stock its 27th largest position. SevenBridge Financial Group LLC’s holdings in Procter & Gamble were worth $5,145,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Concurrent Investment Advisors LLC boosted its holdings in shares of Procter & Gamble by 4.5% in the third quarter. Concurrent Investment Advisors LLC now owns 94,109 shares of the company’s stock worth $16,300,000 after acquiring an additional 4,035 shares during the period. Radnor Capital Management LLC bought a new position in Procter & Gamble in the 3rd quarter worth about $5,705,000. Welch Group LLC grew its holdings in Procter & Gamble by 0.9% during the 3rd quarter. Welch Group LLC now owns 323,870 shares of the company’s stock valued at $56,094,000 after buying an additional 2,990 shares in the last quarter. Swiss National Bank increased its position in shares of Procter & Gamble by 0.6% during the third quarter. Swiss National Bank now owns 7,005,790 shares of the company’s stock valued at $1,213,403,000 after buying an additional 39,000 shares during the period. Finally, GAMMA Investing LLC lifted its holdings in shares of Procter & Gamble by 67.2% in the second quarter. GAMMA Investing LLC now owns 26,803 shares of the company’s stock worth $4,420,000 after buying an additional 10,777 shares in the last quarter. 65.77% of the stock is currently owned by institutional investors.

Insider Buying and Selling at Procter & Gamble

In other news, insider Balaji Purushothaman sold 12,800 shares of the firm’s stock in a transaction that occurred on Thursday, October 24th. The stock was sold at an average price of $168.99, for a total value of $2,163,072.00. Following the completion of the transaction, the insider now owns 11,566 shares in the company, valued at $1,954,538.34. This trade represents a 52.53 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, insider Susan Street Whaley sold 634 shares of the business’s stock in a transaction on Wednesday, October 2nd. The shares were sold at an average price of $171.65, for a total transaction of $108,826.10. Following the sale, the insider now owns 19,341 shares in the company, valued at approximately $3,319,882.65. This trade represents a 3.17 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 160,693 shares of company stock valued at $27,311,345 in the last 90 days. Insiders own 0.18% of the company’s stock.

Analyst Ratings Changes

Several equities analysts recently commented on the stock. Wells Fargo & Company boosted their price objective on shares of Procter & Gamble from $188.00 to $190.00 and gave the company an “overweight” rating in a research note on Friday. Royal Bank of Canada restated a “sector perform” rating and set a $164.00 price target on shares of Procter & Gamble in a research report on Monday, October 21st. Piper Sandler began coverage on Procter & Gamble in a research report on Tuesday, September 24th. They issued a “neutral” rating and a $174.00 price objective on the stock. Barclays cut Procter & Gamble from an “overweight” rating to an “equal weight” rating and set a $163.00 target price for the company. in a research report on Monday, September 30th. Finally, DZ Bank raised Procter & Gamble from a “hold” rating to a “buy” rating and set a $190.00 price target on the stock in a report on Thursday, August 29th. Nine research analysts have rated the stock with a hold rating, thirteen have issued a buy rating and two have given a strong buy rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $178.00.

Check Out Our Latest Analysis on Procter & Gamble

Procter & Gamble Price Performance

Shares of NYSE:PG opened at $176.28 on Friday. The company’s fifty day moving average is $170.04 and its 200 day moving average is $168.64. The company has a quick ratio of 0.55, a current ratio of 0.75 and a debt-to-equity ratio of 0.50. The Procter & Gamble Company has a 52 week low of $142.50 and a 52 week high of $177.94. The stock has a market cap of $415.15 billion, a PE ratio of 30.39, a PEG ratio of 3.74 and a beta of 0.42.

Procter & Gamble (NYSE:PGGet Free Report) last released its earnings results on Friday, October 18th. The company reported $1.93 earnings per share for the quarter, beating analysts’ consensus estimates of $1.90 by $0.03. Procter & Gamble had a return on equity of 33.25% and a net margin of 17.07%. The company had revenue of $21.74 billion during the quarter, compared to analyst estimates of $21.99 billion. During the same quarter in the previous year, the company posted $1.83 EPS. Procter & Gamble’s revenue for the quarter was down .6% on a year-over-year basis. Research analysts anticipate that The Procter & Gamble Company will post 6.94 earnings per share for the current year.

Procter & Gamble Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, November 15th. Stockholders of record on Friday, October 18th were paid a dividend of $1.0065 per share. This represents a $4.03 annualized dividend and a dividend yield of 2.28%. The ex-dividend date was Friday, October 18th. Procter & Gamble’s dividend payout ratio (DPR) is 69.48%.

Procter & Gamble Profile

(Free Report)

The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.

Further Reading

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PGFree Report).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.